Policies in Europe on "marginal quality" donor livers
- 26 November 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 344 (8935) , 1480-1483
- https://doi.org/10.1016/s0140-6736(94)90294-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- THE ROLE OF DYNAMIC AND MORPHOLOGICAL STUDIES IN THE ASSESSMENT OF POTENTIAL LIVER DONORSTransplantation, 1994
- THE UNRELIABILITY OF THE LIDOCAINE/MONOETHYLGLYCINEXYLIDIDE TEST FOR ASSESSMENT OF LIVER DONORSTransplantation, 1993
- RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSISTransplantation, 1993
- Consensus on general medical contraindications to organ donation?BMJ, 1992
- Organ donation from intensive care units in England and Wales: two year confidential audit of deaths in intensive care.BMJ, 1992
- THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2Transplantation, 1992
- THE PREDICTIVE VALUE OF DONOR LIVER BIOPSIES FOR THE DEVELOPMENT OF PRIMARY NONFUNCTION AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1991
- THE USE OF “MARGINAL” DONORS FOR ORGAN TRANSPLANTATION: THE INFLUENCE OF DONOR AGE ON OUTCOMETransplantation, 1991
- PRIMARY NONFUNCTION OF HEPATIC ALLOGRAFTS WITH PREEXISTING FATTY INFILTRATION1Transplantation, 1989
- LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTIONThe Lancet, 1989